Sign in

You're signed outSign in or to get full access.

Marc D. Miller

About Marc D. Miller

Marc D. Miller (age 54) has served on the UHT Board since 2008 (Class II) and is classified as a non‑management, non‑independent trustee. He is CEO and President of Universal Health Services, Inc. (UHS) and the son of Alan B. Miller, UHT’s Chairman, CEO and President, highlighting a familial relationship with UHT’s top executive. He also serves on the UHS board and on the board of Premier, Inc., bringing deep healthcare operating expertise to UHT’s board.

Past Roles

OrganizationRoleTenureCommittees/Impact
Universal Health Services, Inc. (UHS)Chief Executive Officer; PresidentCEO since Jan 2021; President since 2009; with UHS acute care roles since 2000Extensive hospital management experience; member of UHS Board since 2006

External Roles

OrganizationRoleTenureNotes
Universal Health Services, Inc. (UHS)Director; CEO & PresidentDirector since 2006; CEO since 2021; President since 2009UHS is UHT’s advisor and a major tenant; multiple related‑party ties to UHT
Premier, Inc.DirectorNot disclosedPremier has a group purchasing agreement with UHS; potential information/conflict linkage channel

Board Governance

  • Independence: Non‑management, non‑Independent Trustee; familial relationship to UHT’s Chairman/CEO (Alan B. Miller).
  • Committee assignments: Not listed on Audit, Compensation, or Nominating & Governance committees (Audit: McCadden/Capozzalo/Morey; Compensation: Morey/Capozzalo/Domb; Nominating & Governance: Capozzalo/Guzman/McCadden).
  • Attendance/engagement: Board held four regular meetings in 2024; all active trustees participated in substantially all Board and applicable committee meetings; all trustees attended the 2024 annual meeting; independent trustees held four executive sessions.
  • Lead Independent Trustee: Robert F. McCadden.

Fixed Compensation

YearCash Retainer ($)Committee Fees ($)Other Cash ($)Total Cash ($)
20240 0 0 0

Notes:

  • Independent trustee cash retainers were ~$31,142 in 2024 and increased to $32,000 effective June 6, 2024; Marc, as a non‑independent trustee, received no cash fees.

Performance Compensation

Grant DateInstrumentShares GrantedGrant‑Date Fair Value ($)VestingPerformance Metrics
2024‑06‑05Restricted Stock785 30,018 (785 × $38.24) Time‑based; vests on 2nd anniversary; dividends accrue and pay at vesting None disclosed for trustee grants (service‑based vesting)

Director Compensation (2024)

ComponentAmount ($)
Fees Earned or Paid in Cash0
Stock Awards30,018
All Other Compensation (accrued dividends on unvested RS)3,865
Total33,883

Other Directorships & Interlocks

CompanyRoleInterlock/Related‑Party Considerations
UHSDirector; CEO & PresidentUHS is UHT’s advisor (0.70% fee on average invested real estate assets; $5.5m in 2024) and major tenant; UHS owns 5.7% of UHT; leases with UHS contributed ~24–26% of UHT revenue from hospital leases and ~40–41% including wider UHS‑related tenant base in 2022–2024; UHS holds options/rights on leased assets.
Premier, Inc.DirectorPremier has a group purchasing agreement with UHS, indicating a potential information flow/conflict nexus.

Expertise & Qualifications

  • Healthcare operations and hospital management expertise developed over two decades at UHS; current CEO and President of a large health system.
  • Strategic and operational depth relevant to UHT’s tenant base (with UHS a large portion of revenues).

Equity Ownership

HolderShares Beneficially Owned% of OutstandingPledged?Notes
Marc D. Miller6,383 <1% No shares pledged by any UHT trustees/officers Includes restricted shares awarded in 2023–2024 scheduled to vest 2025–2026, subject to forfeiture.

Insider Filings and Trades

Date (Filing)FormIssuerNotes
2025‑10‑30Form 4Universal Health Realty Income Trust (UHT)SEC filing shows Marc D. Miller as reporting person; see filing for transaction details.

Governance Assessment

  • Strengths

    • Sector‑relevant operating expertise; multi‑decade track record at UHS.
    • Board structure features a Lead Independent Trustee, fully independent principal committees, and regular independent executive sessions (four in 2024), supporting oversight despite related‑party exposure.
    • Director equity is time‑vested restricted stock, with dividends deferred until vesting, promoting alignment.
  • Risks and RED FLAGS

    • Not independent; familial relationship with UHT’s Chairman/CEO (his father), which heightens conflict risks and limits committee service.
    • Extensive related‑party exposure to UHS (advisory agreement; lease concentration; purchase/renewal options; UHS ownership stake), creating potential conflicts in capital allocation, asset sales, and lease terms.
    • Interlock signal: Premier board seat while Premier has a GPO arrangement with UHS; though not a direct UHT transaction, it underscores broader network interdependencies.
  • Engagement

    • Board/committee participation was strong in 2024; all trustees attended the 2024 annual meeting.

Policy backdrop:

  • Hedging prohibited; dividends on unvested RS accrue and pay at vesting; clawback policy for executive officers adopted Oct 2, 2023.

Overall implication for investors: Marc D. Miller brings material health system operating insight but is not independent and sits within a web of related‑party ties between UHT and UHS. Continued emphasis on independent committee oversight, rigorous related‑party review, and transparent disclosure of UHS‑linked transactions is essential to sustain investor confidence.